CHD vs PLX · P/E 32, rev $6.11B vs P/E 31, rev $53.4M
Church & Dwight Company Inc (CHD) versus Protalix Biotherapeutics Inc (PLX) — a side-by-side from cached financials, not a winner call.
Church & Dwight Company Inc (CHD) is a household & personal products company listed on NYSE.
Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
Latest reported CHD revenue for 2024-12-31 was $6.11B. Net income was $585.3M. Revenue was up 4.1% from 2023-12-31 to 2024-12-31. CHD currently screens at market cap $23.08B and trailing P/E 32.0.
Latest reported PLX revenue for 2024-12-31 was $53.4M. Net income was $2.9M. Revenue was down 18.5% from 2023-12-31 to 2024-12-31. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
CHD currently screens at market cap $23.08B and trailing P/E 32.0. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
Not investment advice. Open the CHD and PLX stock pages for the full models.
Not investment advice.